Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
A phase II trial of the epothilone B analog, BMS-247550, in patients with previously treated advanced colorectal cancerC Eng, H L Kindler, S Nattam, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1988
Production of a fibronectin-associated lymphokine by cloned mouse T cellsH P Godfrey, L S Canfield, H L Kindler, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junctionA B Sandler, H L Kindler, L H Einhorn, et al.American Journal of Clinical Oncology|October 22, 1998
Phase II trial of topotecan administered as a 21-day continuous infusion in previously untreated patients with stage IIIB and IV non-small-cell lung cancerH L Kindler, M G Kris, I E Smith, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabineS D Undevia, H L Kindler, L Janisch, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2005
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancerH Oettle, D Richards, R K Ramanathan, et al.ESMO Gastrointestinal Oncology|February 6, 2026
Assessment of the impact of FcγRIIIA single-nucleotide polymorphisms on the efficacy of IgG1 monoclonal antibodies in patients with advanced gastroesophageal adenocarcinomaA V Serritella, N K S Grewal, B Peterson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2012
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancerH L Kindler, D A Richards, L E Garbo, et al.Lung Cancer (Amsterdam, Netherlands)|July 23, 2014
Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesotheliomaL M Krug, A J Wozniak, H L Kindler, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 29, 2019
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparibP Hammel, H L Kindler, M Reni, et al.Pageof 2